Characterization of Entamoeba histolytica adenosine 5'-phosphosulfate (APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasis.
<h4>Background</h4>Amoebiasis, caused by Entamoeba histolytica infection, is a global public health problem. However, available drugs to treat amoebiasis are currently limited, and no effective vaccine exists. Therefore, development of new preventive measures against amoebiasis is urgent...
Main Authors: | Fumika Mi-Ichi, Takeshi Ishikawa, Vo Kha Tam, Sharmina Deloer, Shinjiro Hamano, Tsuyoshi Hamada, Hiroki Yoshida |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-08-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0007633 |
Similar Items
-
Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis
by: Nancy Guillén
Published: (2023-12-01) -
Overdiagnosis of amoebiasis in the absence of Entamoeba histolytica among patients presenting with diarrhoea in Wonji and Akaki, Ethiopia.
by: Kebede, A, et al.
Published: (2003) -
Species-specific immunity induced by infection with Entamoeba histolytica and Entamoeba moshkovskii in mice.
by: Chikako Shimokawa, et al.
Published: (2013-01-01) -
The epidemiology of amoebiasis in Thi-Qar Province, Iraq (2015-2020): differentiation of Entamoeba histolytica and Entamoeba dispar using nested and real-time polymerase chain reaction
by: Mohammed Hassan Flaih, et al.
Published: (2021-05-01) -
In Vitro Functional Study of Rice Adenosine 5’-Phosphosulfate Kinase
by: Wang De-zhen, et al.
Published: (2016-05-01)